No article text was recorded for this version.
steatosis-to-inflammation transition
Version 1 of 119 papers23 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development
- Blog: PTPROt aggravates inflammation by enhancing NF-κB activation in liver macrophages during nonalcoholic steatohepatitis
- Blog: SIRT1 upregulation protects against liver injury induced by a HFD through inhibiting CD36 and the NF‑κB pathway in mouse kupffer cells
- Blog: Effect of resveratrol on non‑alcoholic fatty liver disease
- Blog: Magnolol Alleviates Inflammatory Responses and Lipid Accumulation by AMP-Activated Protein Kinase-Dependent Peroxisome Proliferator-Activated Receptor α Activation
- Blog: Berberine Prevents Disease Progression of Nonalcoholic Steatohepatitis through Modulating Multiple Pathways
- Blog: Mastiha (<i>Pistacia lentiscus</i>) Improves Gut Microbiota Diversity, Hepatic Steatosis, and Disease Activity in a Biopsy‐Confirmed Mouse Model of Advanced Non‐Alcoholic Steatohepatitis and Fibrosis
- Blog: A novel small compound TOIDC suppresses lipogenesis via SREBP1-dependent signaling to curb MAFLD
- Blog: The protective roles of augmenter of liver regeneration in hepatocytes in the non-alcoholic fatty liver disease
- Blog: An ATF3 Inducer Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease Through the AMPK and PKA Pathways
- Blog: Dietary cholesterol promotes steatohepatitis related hepatocellular carcinoma through dysregulated metabolism and calcium signaling
- Blog: Myeloid SENP3 deficiency protects mice from diet and age-induced obesity via regulation of YAP1 SUMOylation
- Blog: Upregulation of Early and Downregulation of Terminal Pathway Complement Genes in Subcutaneous Adipose Tissue and Adipocytes in Acquired Obesity
- Blog: Correlation between PPAR-α methylation level in peripheral blood and inflammatory factors of NAFLD patients with DM
- Blog: Pachymic acid alleviates metabolic dysfunction-associated steatotic liver disease by inhibiting ferroptosis through PPARα
- Blog: RAMP1 signaling attenuates diet-induced steatotic liver disease in mice
- Blog: The receptor CD44 is associated with systemic insulin resistance and proinflammatory macrophages in human adipose tissue
- Blog: Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) for the management of nonalcoholic fatty liver disease (NAFLD): A systematic review
- Blog: CircMETTL3-156aa reshapes the glycolytic metabolism of macrophages to promote M1 polarization and induce cytokine storms in sHLH
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_steatosis_to_inflammation_transition_cc7c9605,
title = {steatosis-to-inflammation transition},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/steatosis-to-inflammation-transition/rdr_cc7c960552014c4183c3558bf6ce54ca},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-21},
}This exact version (version 1, frozen text):
@misc{lacuna_steatosis_to_inflammation_transition_cc7c9605_v1,
title = {steatosis-to-inflammation transition},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/steatosis-to-inflammation-transition/rdr_cc7c960552014c4183c3558bf6ce54ca/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-21},
}